Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fossati

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Vaccine|April 20, 2007
A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccinationJuliana Cassataro, Karina A Pasquevich, Silvia M Estein, et al.
Vaccine|September 15, 2009
The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in ramsSilvia M Estein, María A Fiorentino, Fernando A Paolicchi, et al.
International Journal of Cancer|August 2, 2011
Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agentsS Uboldi, S Bernasconi, M Romano, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Vaccine|April 20, 2007
A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccinationJuliana Cassataro, Karina A Pasquevich, Silvia M Estein, et al.
Vaccine|September 15, 2009
The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in ramsSilvia M Estein, María A Fiorentino, Fernando A Paolicchi, et al.
International Journal of Cancer|August 2, 2011
Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agentsS Uboldi, S Bernasconi, M Romano, et al.
Pageof 14